BioHarvest revenue rises 3.8% to $8.8 million
BioHarvest Sciences (NASDAQ:BHST) reported second-quarter 2026 revenue of $8.8 million, up 3.8%, while gross margin slipped to 58%.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
BioHarvest Sciences (NASDAQ:BHST) reported second-quarter 2026 revenue of $8.8 million, up 3.8%, while gross margin slipped to 58%.
Organigram Global (NASDAQ:OGI) reported $145.1 million in third-quarter gross revenue alongside a net income of $105.5 million.
Philips (NYSE:PHG) raised Exor’s permitted ownership cap to 22% from 20% under an updated long-term relationship agreement.
South Korea plans to lower the reporting threshold for cryptocurrency transfers under its Travel Rule, increasing reporting requirements for more transactions.
Brazil’s cryptocurrency market faces a major regulatory deadline in October as crypto companies prepare for new licensing requirements.
Starpharma (ASX:SPL) completed a fully underwritten entitlement offer to raise $32 million in new capital before costs.
Community banks are opposing parts of the CLARITY Act because of concerns about stablecoin reward provisions.
Santos (ASX:STO) shipped its first cargo of 450,000 barrels of crude oil from the Pikka phase 1 development on Alaska's North Slope.
Domino's Pizza Enterprises (ASX:DMP) will appeal a Federal Court ruling requiring a payment of approximately $11,869.33 plus interest to lead applicant Riley Gall.
Losses in Japan’s government bond market have renewed debate about Bitcoin (CRYPTO:BTC) as an alternative asset.